PGD Success Rates

Genea pioneered genetic screening of embryos in 1995 when the first chromosome tests were developed and led the way in developing the technique through the expansion to single gene testing three years later. Our Scientists are constantly innovating and looking for new and better ways to screen genes and help couples achieve their dreams of a baby. Many clinics have followed our lead and modeled their tests on ours.

We offer world leading preimplantation genetic diagnosis (PGD), with the ability to screen for any of the more than 2,000 gene disorders which have been identified. To date we've developed screening for approximately 200 disorders and we’ve built specific tests for each one, including some very rare disorders.

Genea was the first clinic in the world to successfully introduce Preimplantation Genetic Diagnosis (PGD) for Day 5 embryos in 1999, achieving the first baby ever born using this technique. And in 2010, we were the first Australian clinic to offer a new type of screening which allowed a full chromosome count for the first time. This meant more random chromosome abnormalities - one of the main causes of failed IVF cycles and of repeated miscarriages in both fertility patients and women who conceive naturally - could be detected.

Genea is one of the very few centres in Australia with the vital combination of IVF and genetics facilities to perform these sophisticated genetic screening tests successfully. We also dedicate approximately 10 per cent of our revenues each year to researching and developing new testing techniques and methods.

History of PGD at Genea - World Leading PGD

Latest Blog

Genea blog Balancing work and IVF

Read the article